Picture of Emergent BioSolutions logo

EBS — Emergent BioSolutions News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Emergent Biosolutions Receives Approval From Singapore Health Sciences Authority

April 30 (Reuters) - Emergent BioSolutions Inc EBS.N:

EMERGENT BIOSOLUTIONS RECEIVES APPROVAL FROM SINGAPORE HEALTH SCIENCES AUTHORITY FOR EXPANDED INDICATION OF ACAM2000® (SMALLPOX AND MPOX (VACCINIA) VACCINE, LIVE) TO INCLUDE MPOX

Source text: ID:nGNX2d5S0Y

Further company coverage: EBS.N

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Emergent BioSolutions

See all news